AI and Accelerated Computing Solutions for Automotive

AI-Powered Drug Discovery

Advancing Pharma and Biopharma Research With AI and Accelerated Computing

From searching a seemingly endless molecule database to generating molecules to understanding proteins, DNA and RNA, NVIDIA solutions are helping pharmaceutical and biopharmaceutical companies to discover and develop drugs faster and at a lower cost.

Reimagining Drug Discovery With Computational Biology

Drug discovery is slow and expensive despite improvements in technology, making it harder to bring drugs to market. Learn how deep learning methods and GPU-accelerated computing are starting to reverse this trend.

Read E-book: Drug Discovery With Computational Biology >

Use Cases

Discover How AI Is Transforming the Biopharmaceutical Industry

The Conference for the Era of AI and the Metaverse

Developer Conference March 20-23 | Keynote March 21

Don't miss these three upcoming Restaurant sessions at GTC.


Solutions for Every Phase of Drug Discovery and Research

NVIDIA Clara™ drug discovery is a GPU-accelerated computational drug discovery platform that combines AI, data analytics, simulation, and visualization to support cross-disciplinary workflows in drug design and development. Clara for drug discovery helps scientists and researchers get drugs to market faster and enables new possibilities for research into disease mechanisms.

Credit: Mahendra Awale, CC BY-SA 3.0, via Wikimedia Commons

GPU-Accelerated Drug Discovery

Using Cara for drug discovery, researchers can apply high-performance computing applications, pretrained AI models, and domain-specific application frameworks in the areas of genomics, protein structure determination, virtual drug screening, medical imaging, NLP, and more.

Accelerate Early Drug Discovery with Generative AI

NVIDIA BioNeMo Service is a cloud service for generative AI in drug discovery, offering tools to quickly customize and deploy domain-specific, state-of-the-art biomolecular models at-scale through cloud APIs.


Take a Deeper Dive Into AI in Biopharma


Accelerating Drug Discovery With Clara for drug discovery's MegaMolBART

See how NVIDIA Clara for drug discovery's MegaMolBart, a transformer-based NLP model developed with AstraZeneca and trained on millions of molecules, can quickly identify novel molecules for further investigation, increasing the probability of successful downstream experiments.






NVIDIA Partners for Healthcare

Our solutions for the healthcare industry go beyond products. Our partners are here to assist your organization at every level to build and execute transformative AI strategies, products, and services.

Get Started

Take the Next Steps

Stay up to date with the latest healthcare news from NVIDIA.

Label and Train AI Models

Discover How to Unlock the Potential of Your Business

NVIDIA technology and our innovators across multiple disciplines can help you power transformation, innovation, and the future of your organization.

NVIDIA Clara Developer Kits

Discover Training to Meet Your Organization's Goals

The NVIDIA Deep Learning Institute (DLI) offers hands-on training in AI, accelerated computing, and accelerated data science.

NVIDIA Clara Holoscan MGX Platform

Develop Solutions to the Most Complex Challenges

NVIDIA provides access to hundreds of GPU-accelerated containers, models, and SDKs—all the tools necessary to successfully build apps with NVIDIA technology.